RATIONALE: The pulmonary mononuclear phagocyte system is a critical host defense mechanism composed of macrophages, monocytes, monocyte-derived cells, and dendritic cells. However, our current characterization of these cells is limited because it is derived largely from animal studies and analysis of human mononuclear phagocytes from blood and small tissue resections around tumors. OBJECTIVES: Phenotypic and morphologic characterization of mononuclear phagocytes that potentially access inhaled antigens in human lungs. METHODS: We acquired and analyzed pulmonary mononuclear phagocytes from fully intact nondiseased human lungs (including the major blood vessels and draining lymph nodes) obtained en bloc from 72 individual donors. Differential labeling of hematopoietic cells via intrabronchial and intravenous administration of antibodies within the same lobe was used to identify extravascular tissue-resident mononuclear phagocytes and exclude cells within the vascular lumen. Multiparameter flow cytometry was used to identify mononuclear phagocyte populations among cells labeled by each route of antibody delivery. MEASUREMENTS AND MAIN RESULTS: We performed a phenotypic analysis of pulmonary mononuclear phagocytes isolated from whole nondiseased human lungs and lung-draining lymph nodes. Five pulmonary mononuclear phagocytes were observed, including macrophages, monocyte-derived cells, and dendritic cells that were phenotypically distinct from cell populations found in blood. CONCLUSIONS: Different mononuclear phagocytes, particularly dendritic cells, were labeled by intravascular and intrabronchial antibody delivery, countering the notion that tissue and blood mononuclear phagocytes are equivalent systems. Phenotypic descriptions of the mononuclear phagocytes in nondiseased lungs provide a precedent for comparative studies in diseased lungs and potential targets for therapeutics.
RATIONALE: The pulmonary mononuclear phagocyte system is a critical host defense mechanism composed of macrophages, monocytes, monocyte-derived cells, and dendritic cells. However, our current characterization of these cells is limited because it is derived largely from animal studies and analysis of human mononuclear phagocytes from blood and small tissue resections around tumors. OBJECTIVES: Phenotypic and morphologic characterization of mononuclear phagocytes that potentially access inhaled antigens in human lungs. METHODS: We acquired and analyzed pulmonary mononuclear phagocytes from fully intact nondiseased human lungs (including the major blood vessels and draining lymph nodes) obtained en bloc from 72 individual donors. Differential labeling of hematopoietic cells via intrabronchial and intravenous administration of antibodies within the same lobe was used to identify extravascular tissue-resident mononuclear phagocytes and exclude cells within the vascular lumen. Multiparameter flow cytometry was used to identify mononuclear phagocyte populations among cells labeled by each route of antibody delivery. MEASUREMENTS AND MAIN RESULTS: We performed a phenotypic analysis of pulmonary mononuclear phagocytes isolated from whole nondiseased human lungs and lung-draining lymph nodes. Five pulmonary mononuclear phagocytes were observed, including macrophages, monocyte-derived cells, and dendritic cells that were phenotypically distinct from cell populations found in blood. CONCLUSIONS: Different mononuclear phagocytes, particularly dendritic cells, were labeled by intravascular and intrabronchial antibody delivery, countering the notion that tissue and blood mononuclear phagocytes are equivalent systems. Phenotypic descriptions of the mononuclear phagocytes in nondiseased lungs provide a precedent for comparative studies in diseased lungs and potential targets for therapeutics.
Authors: W S Garrett; L M Chen; R Kroschewski; M Ebersold; S Turley; S Trombetta; J E Galán; I Mellman Journal: Cell Date: 2000-08-04 Impact factor: 41.582
Authors: Ingel K Demedts; Guy G Brusselle; Karim Y Vermaelen; Romain A Pauwels Journal: Am J Respir Cell Mol Biol Date: 2004-12-02 Impact factor: 6.914
Authors: Ingel K Demedts; Ken R Bracke; Tania Maes; Guy F Joos; Guy G Brusselle Journal: Am J Respir Cell Mol Biol Date: 2006-04-20 Impact factor: 6.914
Authors: Barbara J Masten; Gwyneth K Olson; Christy A Tarleton; Chad Rund; Mark Schuyler; Reza Mehran; Tereassa Archibeque; Mary F Lipscomb Journal: J Immunol Date: 2006-12-01 Impact factor: 5.422
Authors: Zhikun Zheng; Stephen Chiu; Mahzad Akbarpour; Haiying Sun; Paul A Reyfman; Kishore R Anekalla; Hiam Abdala-Valencia; Daphne Edgren; Wenjun Li; Daniel Kreisel; Farida V Korobova; Ramiro Fernandez; Alexandra McQuattie-Pimentel; Zheng J Zhang; Harris Perlman; Alexander V Misharin; G R Scott Budinger; Ankit Bharat Journal: Sci Transl Med Date: 2017-06-14 Impact factor: 17.956
Authors: Sophie L Gibbings; Stacey M Thomas; Shaikh M Atif; Alexandra L McCubbrey; A Nicole Desch; Thomas Danhorn; Sonia M Leach; Donna L Bratton; Peter M Henson; William J Janssen; Claudia V Jakubzick Journal: Am J Respir Cell Mol Biol Date: 2017-07 Impact factor: 6.914
Authors: Alexandra L McCubbrey; Lea Barthel; Kara J Mould; Michael P Mohning; Elizabeth F Redente; William J Janssen Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-05-17 Impact factor: 5.464